How GlaxoSmithKline Lost Nearly $10B in October Post author:Sam Post published:November 9, 2017 Post category:BioPharma Could GlaxoSmithKline’s industry-leading dividend be at risk? Source: BioSpace You Might Also Like Alder Announces $250M Committed Equity Financing January 7, 2018 American Diabetes Association And Collaborate To Prevent And Delay Type 2 Diabetes September 4, 2017 Egalet Cuts Workforce By 40% in Expense Reduction Plan August 9, 2017
